BAMCO Inc
ANAB icon

BAMCO Inc’s AnaptysBio ANAB Stock Holding History

BAMCO Inc’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,087
Closed -$226K – 361
2019
Q1 		$226K Sell
3,087
-5,030
-62% -$347K ﹤0.01% 314
2018
Q4 		$518K Buy
8,117
+924
+13% +$68.7K ﹤0.01% 314
2018
Q3 		$718K Buy
7,193
+5,710
+385% +$474K ﹤0.01% 319
2018
Q2 		$105K Sell
1,483
-5,169
-78% -$434K ﹤0.01% 326
2018
Q1 		$692K Buy
+6,652
New +$750K ﹤0.01% 305

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc's ANAB Position: Q2 2019 in Review

BAMCO Inc sold out of AnaptysBio (ANAB) in Q2 2019, closing a stake of 3,087 shares — an estimated $226K sold.

BAMCO Inc first reported a position in ANAB in Q1 2018 and held it in 5 quarters. The position peaked at $718K in Q3 2018. 127 funds tracked by Wall St. Rank hold ANAB as of Q2 2019.

  • BAMCO Inc reported no remaining AnaptysBio position as of Q2 2019 after selling out during the quarter.
  • BAMCO Inc sold 3,087 AnaptysBio shares in Q2 2019, an estimated $226K.
  • BAMCO Inc first reported a position in AnaptysBio in Q1 2018 and held it in 5 quarters.
  • BAMCO Inc's AnaptysBio position peaked at $718K in Q3 2018.
  • 127 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2019.

Based on BAMCO Inc's 13F filing for Q2 2019, filed 15 Aug 2019.